Π. Ζαρογουλίδης-Γ.Κουτέπας: Το Φαρμακείο ως επιχείρηση...

75
Επιχείρηση Φαρμακείο: Όρια & Προκλήσεις Γιώργος Κουτέπας Φαρμακοποιός Πτυχίο Επιχειρησιακής Ερευνας & Marketing Αντιπρόσωπος Φ.Σ Αττικής στον ΠΦΣ Πάνος Ζαρογουλίδης Φαρμακοποιός, MBA Αντιπρόεδρος Φ.Σ Πέλλας Αντιπρόσωπος Φ.Σ Πέλλας στον ΠΦΣ 1

Transcript of Π. Ζαρογουλίδης-Γ.Κουτέπας: Το Φαρμακείο ως επιχείρηση...

PowerPoint Presentation

: & & Marketing .

, MBA . .

1 .

, , .. .12 ; 5 ; , , , . . .

1/3 470 , 1 5 . - ;- 2/3! , 60% , 50% , , . , , , . Kapa Research- : . 16-10-2014 www.in.gr

: & 334

. . . .

: &

556 -

7 , .

.

.

.

8 -

9 (- )= (- )(- )(- )=

(-) - : &

10

: &

11Pharma Reports

: &

12

(, , , )

: &

1313

: &

1415

16

17

( )

18

(!!! )

19

=

(, , , ) (Break Even Point)

: &

2020

21Break Even Point : ( ), , .

, (break even point), .

, , .

=

22 &

, : &

23 &

: &

24 .

(, , , ) (Break Even Point) , ,

: &

2525 (Cash Flow) () 5.000,00 7.000,00 1.200,00 9.000,00 9.000,00 () 10.000,00 11.500,00 5.000,00 15.000,00 13.000,00 15.000,00 18.500,00 6.200,00 24.000,00 22.000,00 11.538,46 14.230,77 4.769,23 18.461,54 16.923,08 2.000,00 800,00 700,00 1.400,00 1.200,00 16001600160016001600 15.138,46 16.630,77 7.069,23 21.461,54 19.723,08 - 138,46 1.869,23 - 869,23 2.538,46 2.276,92 15.000,00 14.861,54 16.730,77 15.861,54 18.400,00 - 138,46 1.869,23 - 869,23 2.538,46 2.276,92 14.861,54 16.730,77 15.861,54 18.400,00 20.676,92 : &

26

(, , , ) (Break Even Point) , ,

: &

2727 ... =( 365) : &

28

: &

2930 . ( ) .

,

( )

31 . .

.

32 /

=

33 =

34 .(- )= (- )(- )(- )=

35 * (- * )= (- )(- )(- )=

36 (. , , )

37 . 10 ... 13 25% 24 () 15% 6 () 12 /3 () 7,5 * 24 = 180 13 * 24 = 312 = 312-180=132 = 42,3% 132/180 = 73,3%() 8,5*6*4 = 204 13 * 24 = 312 = 312-204=108 = 34,6% 108/51 = 211.7% () >?< () 129 ?-> 24

38 . 20 ... 26 25% 24 () 15% 6 () 12 /3 () 15 * 24 = 360 26 * 24 = 624 = 624-360=264 264/360 = 73,3%

() 17 *6 *4 = 408 26 * 24 = 624 = 624-408=216 216/102 = 211,7% () >?< () 258 ?-> 48

39

1+2+..+ =

40 () 10% ; . 20 ... 26 25% 24 () 15% 6 () () 15 /3 (23,4) ->10% () 9 / 3 (24,7) ->5% () 15 * 30 = 450 23,4 * 30 = 702 = 702-450=252 = 35,9% 252/450 = 56%

() 17 *6 *3 = 306 24,7 * 18 = 444,6 = 444,6-306=138,6 = 31,1% 138,6/102 = 135,8% () >?< () 348 ?-> -12 ->-77.4 () !!! -> 113.4

41

.

, , ,

42 : ,

, .

43

!

44

-> -> ; = P*QP2*Q2 >?< P1*Q1 ;. 15 *10 >?< 12 *12 14?

45 C tabeff 5 .() 30 30%() 6 10%() 6 8 () 6 10 (+) (+)(+) 30 * 3,5 = 105 30 * 6 = 180 180 105 = 75 = 75/180 = 41% = 75/105 = 71,42%(+) 6 * 4,5 = 27 18 * 8 = 144 144 (3 * 27) = 63 = 63/144 = 43,75% = 63/27 = 233%

( + ) : 105 -> 75( + ) : 27 -> 63

46 . . , . !!

47 . ( ) ( ) !

48 (- )=

- - - = - = P1*Q1 + P2 * Q2 + P *Q(p1 * q1 + . + p * q)=

(, , )( + )(, )( )= - (, , )

1,944 20141,959 20151,945 2016-2018

49 Delloite 2015 2015 . .

.

50 2050 37% 60

86% 60% 65 75%

700

9% 14% .., 2/3 .

http://www.abbvie.com/content/dam/abbviecorp/us/desktop/sustainablehealthcare/images/EU-Call-To-Action.pdf

51

52

2015. , , .

, , .

, , . .

53

54 ( -) ,

, -

&

generics (, , )

,

55

56

57

.

.

, , ,

5859

60 ( ;) !! ;

61

62 ; ; ; ; ;

63 ; .

.

64 7,5 10 12 / 3

7 18 / 3

54 30% .

54 * (7 5,25) = 94,5 94,5/283,5 = 33%

36 * (10 7,5 ) = 90 90/270 = 33%

65 ! 12 / 3 15 / 3

.

(45 * 7 54 * 5,25) = 31,5 / 283,5 = 11,11%

;

66 . !

. !

( )

.

67

; ; ; ; ; ; ;

68: , ,

: ( , , . : ( , )

69:

-

70 4 5 . . o 4-5 . (stent) 8,860e 10,440e. bypass 12,840e 13,373e. 156,4 90 . . 1,79 . . 20% . .

, ,

71 . :

30 .

1 3% . 2 .

.

15 . .

.

(HbA1c 7%) 1570 euro (60% ).

( 50 60% ) 2900 2,3 12 15% .72

2012 7.100 56% - 15% () 500 8% 9% (800 900 ) , 3% 4% .73

, , (analytics) , .

, , .

, , .

74

.

. . , , , , , , .

, .

. , , .

75134254.29819993.012583.8337640.9662538.596819.7248512.5777518.04193066546.65580589195.3136800.96472907.25988.0424967.6338538.52130.6

-

( - . ) - - /REBATE/ 1 1/ 172922.57 2583.83 2 2/ 297511.63 - 3 3/ 3649558.81 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 0000002583.83000819993.010

6.5 13% 23% 6.5% 13% 23% 6.5% 13% 23% 0%

2012 + 13%67,704.29 16,414.09 84,118.38 13.31%11,195.81 72,922.57 2583.8324,467.50 622.00 0%1072.0523%103,932.05 682.48 104,614.53 6.79%7,102.90 97,511.63 2,137.82 1,547.00 23%5668.036.50%263,536.03 515,899.72 779,435.75 16.66%129,876.94 649,558.81 1,058.71 56,655.00 6.50%79.64REBATE-4,338.26 -4,338.26 16.11% 1,024.95 1,482.00 963,830.40 15.37%148,175.65 819,993.01 5,568.49 13.00 493.49 2,039.59 480.00 180.00 2,410.00 963,830.403.55%34,254.2985.08%819,993.012,583.833.91%37,640.966.49%62,538.590.71%6,819.72 - 34254.29819993.012583.8337640.9662538.596819.7234,254.29 - 819,993.01 2,583.83 37,640.96 - 62,538.59 6,819.72

2013 2013 + 13%77,192.00 26,174.00 103,366.00 22.48%23,232.68 80,133.32 193042,143.00 769.00 0%4612.3223%106,222.00 1,037.44 107,259.44 13.87%14,877.60 92,381.84 4,213.00 1,590.00 23%4439.526.50%277,755.00 491,962.06 769,717.06 21.40%164,714.18 605,002.88 1,289.00 52,123.00 6.50%143.47REBATE-18,582.00 -18,582.00 18.99% 2,001.00 1,500.00 961,760.50 19.16%202,824.46 777,518.04 11,112.65 20.00 1,450.00 1,876.00 510.00 180.00 1,020.00 oaee2,808.00 961,760.505.04%48,512.5080.84%777,518.041,930.006.92%66,546.656.04%58,058.000.96%9,195.3148,512.50777,518.041,930.0066,546.6558,058.009,195.31

363264.7266548.29453019.97

2014

1 201220132014 34,254.29 48512.536800.96819,993.01 777518.04472907.252,583.83 1930988.04- 37,640.96 66546.6524967.63 62,538.59 5805838538.56,819.72 9195.312130.6

1000000000000000000

-

2014 2013 + 13%44,994.72 18,270.00 63,264.72 23.00%14,549.57 48,715.15 988.0416,802.00 184.00 0%31223%65,815.45 732.84 66,548.29 -0.45%-296.23 66,844.52 404.00 1,066.00 23%17306.50%191,813.99 261,205.98 453,019.97 21.12%95,672.39 357,347.58 1,633.17 34,749.04 6.50%88.6REBATE-6,500.00 21.12% 404.56 1,179.00 576,332.98 17.95%109,925.73 472,907.25 4,647.16 20.00 452.74 1,250.00 114.00 90.46 510.00 oaee576,332.986.39%36,800.9682.05%472,907.25988.044.33%24,967.636.69%38,538.500.37%2,130.6036,800.96472,907.25988.0424,967.6338,538.502,130.60